Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study

Dana Dabelea, Catherine Pihoker, Jennifer W Talton, Ralph B D'Agostino Jr, Wilfred Fujimoto, Georgeanna J Klingensmith, Jean M Lawrence, Barbara Linder, Santica M Marcovina, Elizabeth J Mayer-Davis, Giuseppina Imperatore, Lawrence M Dolan, SEARCH for Diabetes in Youth Study, Dana Dabelea, Catherine Pihoker, Jennifer W Talton, Ralph B D'Agostino Jr, Wilfred Fujimoto, Georgeanna J Klingensmith, Jean M Lawrence, Barbara Linder, Santica M Marcovina, Elizabeth J Mayer-Davis, Giuseppina Imperatore, Lawrence M Dolan, SEARCH for Diabetes in Youth Study

Abstract

Objective: To describe an etiologic approach to classification of diabetes types in youth based on the 1997 American Diabetes Association (ADA) framework, using data from the SEARCH for Diabetes in Youth Study.

Research design and methods: SEARCH conducted a comprehensive assessment of 2,291 subjects aged <20 years with recently diagnosed diabetes. Using autoimmunity (at least one of two diabetes autoantibodies) and insulin sensitivity (equation validated against hyperinsulinemic-euglycemic clamps) as the main etiologic markers, we described four categories along a bidimensional spectrum: autoimmune plus insulin-sensitive (IS), autoimmune plus insulin-resistant (IR), nonautoimmune plus IS, and nonautoimmune plus IR. We then explored how characteristics, including genetic susceptibility to autoimmunity (HLA genotypes), insulin deficiency, and clinical factors varied across these four categories.

Results: Most subjects fell into either the autoimmune plus IS (54.5%) or nonautoimmune plus IR categories (15.9%) and had characteristics that align with traditional descriptions of type 1 or type 2 diabetes. The group classified as autoimmune plus IR (19.5%) had similar prevalence and titers of diabetes autoantibodies and similar distribution of HLA risk genotypes to those in the autoimmune plus IS group, suggesting that it includes individuals with type 1 diabetes who are obese. The group classified as nonautoimmune plus IS (10.1%) likely includes individuals with undetected autoimmunity but may also include those with monogenic diabetes and thus requires further testing.

Conclusions: The SEARCH study offers researchers and clinicians a practical application for the etiologic classification of diabetes type and at the same time identifies a group of youths who would benefit from further testing.

Figures

Figure 1
Figure 1
Proportional distribution of etiologic categories among SEARCH participants by race/ethnicity

References

    1. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039–1057
    1. American Diabetes Association Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–1197
    1. Gale EA: Declassifying diabetes. Diabetologia 2006;49:1989–1995
    1. Dabelea D, Bell RA, D’Agostino RB, Jr, et al. ; Writing Group for the SEARCH for Diabetes in Youth Study Group Incidence of diabetes in youth in the United States. JAMA 2007;297:2716–2724
    1. Ingram DD, Parker JD, Schenker N, et al. United States Census 2000 population with bridged race categories: data evaluation and methods research. Vital Health Stat II 2003;135:1–55
    1. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 Centers for Disease Control and Prevention Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;246:1–190
    1. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439–444
    1. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care 1999;22:1655–1659
    1. Rewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, Schwartz ID, Imperatore G, Williams D, Dolan LM, Dabelea D. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008;121:e1258–e1266
    1. Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95:3360–3367
    1. Erlich H, Valdes AM, Noble J, et al. ; Type 1 Diabetes Genetics Consortium HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084–1092
    1. Dabelea D, D’Agostino RB, Jr, Mason CC, et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2011;54:78–86
    1. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003;26:832–836
    1. Sabbah E, Savola K, Kulmala P, et al. ; The Childhood Diabetes In Finland Study Group Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab 1999;84:1534–1539
    1. Bakhtadze E, Borg H, Stenstrom G, Fernlund P, Arnqvist HJ, Ekbom-Schnell A, Bolinder J, Eriksson JW, Gudbjornsdottir S, Nystrom L, Groop LC, Sundkvist G. HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia 2006;49:1785–1794
    1. Fourlanos S, Varney MD, Tait BD, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008;31:1546–1549
    1. Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crino A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G, the IMDIAB Group. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). Diabetologia 2000;43:1000–1004
    1. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents: an emerging problem. Endocrinol Metab Clin North America 1999;28:709–729
    1. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100:84–91
    1. Horton V, Stratton I, Bottazzo GF, et al., the UK Prospective Diabetes Study (UKPDS) Group. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 1999;42:608–616
    1. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 2003;26:2876–2882
    1. Lernmark A. Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N Engl J Med 2000;342:344–345
    1. Kimpimäki T, Kulmala P, Savola K, et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002;87:4572–4579
    1. Wenzlau JM, Moua O, Sarkar SA, et al. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci 2008;1150:256–259
    1. Gilliam LK, Pihoker C, Ellard S, et al. Unrecognized Maturity-Onset Diabetes of the Young (MODY) due to HNF1-alpha Mutations in the SEARCH for Diabetes in Youth Study. Diabetes 2007;56(Suppl. 1):A74–A75

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj